309 related articles for article (PubMed ID: 12883485)
1. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.
Kugelmas M; Hill DB; Vivian B; Marsano L; McClain CJ
Hepatology; 2003 Aug; 38(2):413-9. PubMed ID: 12883485
[TBL] [Abstract][Full Text] [Related]
2. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis.
Torer N; Ozenirler S; Yucel A; Bukan N; Erdem O
Scand J Gastroenterol; 2007 Sep; 42(9):1095-101. PubMed ID: 17710676
[TBL] [Abstract][Full Text] [Related]
3. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K
Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116
[TBL] [Abstract][Full Text] [Related]
4. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.
Harrison SA; Torgerson S; Hayashi P; Ward J; Schenker S
Am J Gastroenterol; 2003 Nov; 98(11):2485-90. PubMed ID: 14638353
[TBL] [Abstract][Full Text] [Related]
6. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis.
Abiru S; Migita K; Maeda Y; Daikoku M; Ito M; Ohata K; Nagaoka S; Matsumoto T; Takii Y; Kusumoto K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
Liver Int; 2006 Feb; 26(1):39-45. PubMed ID: 16420507
[TBL] [Abstract][Full Text] [Related]
7. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
8. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
9. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin.
Gonciarz M; Gonciarz Z; Bielanski W; Mularczyk A; Konturek PC; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2010 Dec; 61(6):705-10. PubMed ID: 21224501
[TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study.
Yakaryilmaz F; Guliter S; Savas B; Erdem O; Ersoy R; Erden E; Akyol G; Bozkaya H; Ozenirler S
Intern Med J; 2007 Apr; 37(4):229-35. PubMed ID: 17388862
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study.
Lavine JE
J Pediatr; 2000 Jun; 136(6):734-8. PubMed ID: 10839868
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia.
Hyogo H; Tazuma S; Arihiro K; Iwamoto K; Nabeshima Y; Inoue M; Ishitobi T; Nonaka M; Chayama K
Metabolism; 2008 Dec; 57(12):1711-8. PubMed ID: 19013295
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
Satapathy SK; Garg S; Chauhan R; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
Am J Gastroenterol; 2004 Oct; 99(10):1946-52. PubMed ID: 15447754
[TBL] [Abstract][Full Text] [Related]
14. Cytokine responses at high altitude: effects of exercise and antioxidants at 4300 m.
Hagobian TA; Jacobs KA; Subudhi AW; Fattor JA; Rock PB; Muza SR; Fulco CS; Braun B; Grediagin A; Mazzeo RS; Cymerman A; Friedlander AL
Med Sci Sports Exerc; 2006 Feb; 38(2):276-85. PubMed ID: 16531896
[TBL] [Abstract][Full Text] [Related]
15. Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-alpha.
Ramirez-Tortosa MC; Ramirez-Tortosa CL; Mesa MD; Granados S; Gil A; Quiles JL
Free Radic Biol Med; 2009 Oct; 47(7):924-31. PubMed ID: 19539747
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients.
Khoruts A; Stahnke L; McClain CJ; Logan G; Allen JI
Hepatology; 1991 Feb; 13(2):267-76. PubMed ID: 1995437
[TBL] [Abstract][Full Text] [Related]
18. Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat.
Raso GM; Esposito E; Iacono A; Pacilio M; Cuzzocrea S; Canani RB; Calignano A; Meli R
Eur J Pharmacol; 2009 Feb; 604(1-3):125-31. PubMed ID: 19135440
[TBL] [Abstract][Full Text] [Related]
19. L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial.
Malaguarnera M; Gargante MP; Russo C; Antic T; Vacante M; Malaguarnera M; Avitabile T; Li Volti G; Galvano F
Am J Gastroenterol; 2010 Jun; 105(6):1338-45. PubMed ID: 20068559
[TBL] [Abstract][Full Text] [Related]
20. Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease.
Schäfer C; Schips I; Landig J; Bode JC; Bode C
Z Gastroenterol; 1995 Sep; 33(9):503-8. PubMed ID: 8525652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
